newsfilter
← Latest News
PR Newswire·

Innovative Inhaled Drug Delivery Developer Aerami Therapeutics to Merge with Special Purpose Acquisition Company FoxWayne Enterprises Acquisition Corp. to Become Public Company

DURHAM, N.C. and NEW YORK, Dec. 7, 2021 /PRNewswire/ -- Aerami Therapeutics Holdings, Inc. ("Aerami" or the "Company"), a biopharmaceutical company focused on developing inhaled therapies to treat severe respiratory and chronic diseases, and FoxWayne Ent